Orchard Therapeutics Nabs $150M Series C Posted by dumbcapital | Aug 15, 2018 | Raises and Exits, Uncategorized | 0 | BOSTON, MA, Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million.